PTC Therapeutics, Inc. (PTCT) Capital expenditures 2016–2025
PTC Therapeutics, Inc. (PTCT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$8.9MFY2025 · since FY2016: $1.8M → $8.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.9M | +36.3% |
| FY2024 | $6.5M | -77.1% |
| FY2023 | $28.4M | -11.2% |
| FY2022 | $32.0M | +13.5% |
| FY2021 | $28.2M | +58.1% |
| FY2020 | $17.8M | +29.7% |
| FY2019 | $13.8M | +93.8% |
| FY2018 | $7.1M | +128.9% |
| FY2017 | $3.1M | +74.6% |
| FY2016 | $1.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice